Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. AMLX has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
AMLX stock price ended at $4.85 on Friday, after rising7.3%
The Amylyx Pharmaceuticals Inc stock price increased by 7.3% on the last trading day (16 May 2025), rising from 4.52 to 4.85. Throughout the last trading session, the stock experienced a fluctuation of 8.50% , ranging from a day low of $4.47 to a day high of 4.85. The price has declined in 6 of the last 10 days, resulting in a total change of -8.83% during this period. On the last day, trading volume increase by 351.43K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 797.69K shares were traded, amounting to approximately 3.74M.
AMLX Technical Signals
AMLX(Amylyx Pharmaceuticals Inc Corp) has 5 buy signals and 2 sell signals now. The current trend is downtrend starting from 2025-05-01. The total price change during this trend is -14.40%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of AMLX over the last 5 trading days is 3.30M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
AMLX Moving Average Analysis
Amylyx Pharmaceuticals Inc's overall moving average trend leans more bullish as of Saturday, May 17, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $5.566013333333333, and $6.0473333333333334. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $4.008653333333334, and $3.527333333333334. A break-down below any of these levels will issue sell signals.
AMLX Short Selling Analysis
The short sale ratio of Amylyx Pharmaceuticals Inc(AMLX) as of 12 May 2025 is 8.54%, dropping from last trading day. With decreasing price from 4.61 to 4.60. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary
Sell
2
Buy
5
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
5 Bullish Signals
5 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
14.154
Bullish
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.213
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.114
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
1.627
Bullish
Williams %R (14 days)
WILLR_14 < -80
-85.185
Bullish
2 Bearish Signals
2 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 < 0
-0.74
Bearish
Moving Average
10-day SMA crosses below 20-day SMA
--
Bearish
AMLX Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Amylyx Pharmaceuticals Inc(AMLX), our algorithm predicts AMLX's 1-month price at $4.70, with an 1.89%upwardshift. Using a similarity score up to 98.16%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Amylyx Pharmaceuticals Inc (AMLX.O) stock, as of Sunday, May 11, 2025 , forecasts a 1.89% change over the next month, based on its high correlation with WAT.N stock patterns. The similarity between their price movements over the analyzed periods is 98.16%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
AMLX
No Data
WAT
Up: 1.89%Similarity: 98.16%
Name
Similarity
Up/Down
WAT.N
98.16%
+1.89%
WTRG.N
97.99%
+0.61%
CMPS.O
97.95%
+4.22%
UCTT.O
97.94%
+23.63%
GBR.A
97.73%
-5.56%
THRM.O
97.73%
-6.87%
KEQU.O
97.71%
+1.56%
SMLR.O
97.71%
-7.83%
DRD.N
97.71%
-5.60%
UAVS.A
97.70%
-9.03%
AMLX Seasonality Analysis
Based on AMLX's historical stock price data across all years, the probability of a positive return in May is0.00%, suggesting it maynotbe an ideal month to invest in AMLX. In contrast,Julyoffers the highest probability of positive returns at100.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Amylyx Pharmaceuticals Inc (AMLX.O) stock in July has the highest probability of a positive return (100.00%), while May has the lowest probability (0.00%).
Performance Seasonality
The chart shows Amylyx Pharmaceuticals Inc. (AMLX)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Amylyx Pharmaceuticals Inc (AMLX.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. AMLX has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Amylyx Pharmaceuticals Inc (AMLX.O) stock in a year?
The radar chart shows that buying Amylyx Pharmaceuticals Inc (AMLX.O) stock in July has the highest probability of a positive return (100.00%), while May has the lowest probability (0.00%).
How has Amylyx Pharmaceuticals Inc. (AMLX)'s stock price performed over the past three years?
AMLX's stock price fell by -59.09% in 2023,decreased by -74.75% in 2024, and went up by 22.12% in 2025.
Bearish technical signals of AMLX include: MOM_10 < 0, 10-day SMA crosses below 20-day SMA.
Is AMLX a buy based on overall technical signals summary?
AMLX has 5 buy signals and 2 sell signals now. Overall the technical rating for AMLX is Buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of AMLX.
What is the trend of Amylyx Pharmaceuticals Inc (AMLX)'s moving average?
Amylyx Pharmaceuticals Inc's overall moving average trend leans more bullish as of May 17 2025, with 1 negative signals and 3 positive signal.
What is price prediction for AMLX stock next month?
The price prediction chart for Amylyx Pharmaceuticals Inc (AMLX.O) stock, as of May 11 2025, forecasts a 1.89% change over the next month, based on its high correlation with WAT stock patterns. The similarity between their price movements over the analyzed periods is 98.16%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for AMLX Stock?
The price prediction for AMLX stock in 2025 is **$16.00**, driven by strong buy ratings and a price target from HC Wainwright & Co. The stock is currently undervalued, with positive momentum and commercialization efforts expected to boost its price.
What is price prediction 2030 for AMLX Stock?
The price prediction for AMLX stock by 2030 is expected to reach **$12.50** based on current trends and analyst sentiment. The stock is currently trading at $4.6 with a median analyst price target of $9.50, indicating significant upside potential. Strong buy ratings and partnerships in the pharmaceutical sector support this bullish outlook.